Explore the scientific publications that validate and advance our approach to ALK targeted immunotherapies, from foundational discoveries to clinical translation.
Our approach combines precision immunology and T-cell engineering to create therapies that detect and eliminate ALK-driven tumors with unmatched specificity—offering new hope where resistance has taken hold.
Shaping a future where ALK+ cancers no longer dictate the outcome.
